Correction to: Trials 21, 702 (2020)
https://doi.org/10.1186/s13063-020-04616-4
Following the publication of the original article [1], we were notified of the below corrections:
1- In the Intervention and Comparator section, Phosphate is erroneously mentioned.
2- In the Participants section, “Participants of any gender or age group having tested positive” should read “Participants of either gender above 18 years of age”.
Reference
Akram J, et al. Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of hydroxychloroquine, oseltamivir and azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A structured summary of a study protocol for a randomized controlled trial. Trials. 2020;21:702. https://doi.org/10.1186/s13063-020-04616-4.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Akram, J., Azhar, S., Shahzad, M. et al. Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trial. Trials 23, 150 (2022). https://doi.org/10.1186/s13063-022-06080-8
Published:
DOI: https://doi.org/10.1186/s13063-022-06080-8